• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Influenza Vaccines: 4 Questions on What to Order, Which to Use

Quiz
Article

Influenza continues to rage in some parts of the US; try these 4 quick questions on vaccines you may or may not have on hand.

Influenza Vaccines: 4 Questions on What to Order, Which to Use image Terry Brenneman, MD
Terry Brenneman, MD

Pre-orders for the following year's flu vaccine usually start in January and need to be completed by sometime in March. Let's take a look back at the season in progress and see what you know about the 2023-2024 vaccines.

Question 1. How many quadrivalent influenza vaccines were FDA-licensed for use in the US as of December 2023?


Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Related Content
Breathlessness Related to Medical Conditions in Middle-Aged Adults: Daily Dose / image credit: ©New Africa/AdobeStock

Breathlessness Related to Medical Conditions in Middle-Aged Adults: Daily Dose

April 23rd 2024
Article

Your daily dose of the clinical news you may have missed.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

FDA Approves Benralizumab as Add-On Maintenance Therapy for Children with Severe Asthma: Daily Dose / image credit: ©New Africa/AdobeStock

FDA Approves Benralizumab as Add-On Maintenance Therapy for Children with Severe Asthma: Daily Dose

April 19th 2024
Article

Your daily dose of the clinical news you may have missed.

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

May 20th 2022
Podcast

In our latest podcast episode, Njira Lugogo, MD, discusses NAVIGATOR data she presented at ATS 2022 that showed clinical responses to treatment with tezepelumab.

Tezepelumab for COPD Moves into Phase 3 Planning, Says Amgen / image credit Amgen logo ©MichaelVi/stock.adobe.com

Tezepelumab for COPD Moves into Phase 3 Planning

April 17th 2024
Article

Tezepelumab, a TSLP inhibitor, reduced COPD exacerbations in individuals with moderate/very severe COPD, regardless of baseline BEC and inflammatory drivers, Amgen said.

New Research Suggests Cardiac Events are Prevalent in Older Adults Hospitalized with RSV / Image credit: ©Kateryna Kon/AdobeStock

New Research Suggests Cardiac Events are Prevalent in Older Adults Hospitalized with RSV

April 16th 2024
Article

Nearly one-quarter of hospitalized adults aged 50 years and older with RSV experienced an acute cardiac event, according to results of a new study.

© 2024 MJH Life Sciences

All rights reserved.